-
1دورية أكاديمية
المؤلفون: Anaïs Wambecke, Mohammad Ahmad, Pierre‐Marie Morice, Bernard Lambert, Louis‐Bastien Weiswald, Mégane Vernon, Nicolas Vigneron, Edwige Abeilard, Emilie Brotin, Martin Figeac, Pascal Gauduchon, Laurent Poulain, Christophe Denoyelle, Matthieu Meryet‐Figuiere
المصدر: Molecular Oncology, Vol 15, Iss 12, Pp 3659-3678 (2021)
مصطلحات موضوعية: ceRNA, chemoresistance, miR‐27a‐5p, ovarian cancer, patient‐derived organoid, lncRNA UCA1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Matthieu Meryet-Figuiere, Mégane Vernon, Mamy Andrianteranagna, Bernard Lambert, Célia Brochen, Jean-Paul Issartel, Audrey Guttin, Pascal Gauduchon, Emilie Brotin, Florent Dingli, Damarys Loew, Nicolas Vigneron, Anaïs Wambecke, Edwige Abeilard, Emmanuel Barillot, Laurent Poulain, Loredana Martignetti, Christophe Denoyelle
المصدر: Cancers, Vol 13, Iss 16, p 3970 (2021)
مصطلحات موضوعية: network, multi-omics, miRNA, miR-491-5p, ovarian cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Nicolas Vigneron, Matthieu Meryet-Figuière, Audrey Guttin, Jean-Paul Issartel, Bernard Lambert, Mélanie Briand, Marie-Hélène Louis, Mégane Vernon, Pierre Lebailly, Yannick Lecluse, Florence Joly, Sophie Krieger, Stéphanie Lheureux, Bénédicte Clarisse, Alexandra Leconte, Pascal Gauduchon, Laurent Poulain, Christophe Denoyelle
المصدر: Molecular Oncology, Vol 10, Iss 7, Pp 981-992 (2016)
مصطلحات موضوعية: Circulating miRNA, Serum, Plasma, Profiling, Normalization, Ovarian cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4
المؤلفون: Christophe Denoyelle, Laurent Poulain, Pascal Gauduchon, Cécile Blanc-Fournier, Marie-Hélène Louis, Florence Giffard, Edwige Abeilard, Anaïs Wambecke, Nicolas Vigneron, Hippolyte Paysant, Louis-Bastien Weiswald, Emilie Brotin, Matthieu Meryet-Figuière, Bernard Lambert, Mégane Vernon
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e171fe93114453568b49b67d90e86f8
https://doi.org/10.1158/1535-7163.c.6542257 -
5دورية أكاديمية
-
6دورية أكاديمية
-
7
المؤلفون: Christophe Denoyelle, Pascal Gauduchon, Martin Figeac, Emilie Brotin, Nicolas Vigneron, Louis-Bastien Weiswald, Anaïs Wambecke, Mégane Vernon, Laurent Poulain, Mohammad Ahmad, Matthieu Meryet-Figuière, Edwige Abeilard, Bernard Lambert, Pierre-Marie Morice
المصدر: Molecular Oncology
Molecular Oncology, Vol 15, Iss 12, Pp 3659-3678 (2021)مصطلحات موضوعية: Cancer Research, lncRNA UCA1, medicine.medical_treatment, patient‐derived organoid, Downregulation and upregulation, Cell Line, Tumor, Genetics, Humans, Medicine, Survival rate, RC254-282, Research Articles, Sensitization, Cell Proliferation, Ovarian Neoplasms, Cisplatin, Chemotherapy, Competing endogenous RNA, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, chemoresistance, ceRNA, General Medicine, medicine.disease, miR‐27a‐5p, Gene Expression Regulation, Neoplastic, MicroRNAs, ovarian cancer, medicine.anatomical_structure, Oncology, Cell culture, Ubiquitin-Conjugating Enzymes, Cancer research, Molecular Medicine, Female, RNA, Long Noncoding, business, Ovarian cancer, Research Article, medicine.drug
-
8
المؤلفون: Pierre-Marie Morice, Bernard Lambert, Louis-Bastien Weiswald, Laurent Poulain, Elodie Coquan, Dominique Vaur
المصدر: Br J Cancer
مصطلحات موضوعية: Cancer Research, Treatment response, Tumour heterogeneity, Clinical Decision-Making, Context (language use), Poly(ADP-ribose) Polymerase Inhibitors, Bioinformatics, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Gene panel, medicine, Animals, Humans, Homologous Recombination, business.industry, Patient Selection, High-Throughput Nucleotide Sequencing, Cancer, Patient survival, Sequence Analysis, DNA, medicine.disease, Xenograft Model Antitumor Assays, Phenotype, Organoids, Oncology, 030220 oncology & carcinogenesis, Mutation, Perspective, PARP inhibitor, business
-
9
-
10